Kaitlyn Krebs, DVM,MBA, and Kristen White, DVM, break down the latest vaccine changes for canine and feline patients in this interview with dvm360 Updated feline and canine vaccination guidelines have ...
Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...
Zoetis Inc. (NYSE: ZTS) today announced that it has recently launched Lenivia® (izenivetmab injection) in Canada and the European Union (EU) member states – a new long-acting monoclonal antibody (mAb) ...
At‑home autoinjector option offers new flexibility for patients and care partners Eisai and Biogen have announced that the U.S. Food and Drug Administration has approved a supplemental biologics ...
TOKYO and CAMBRIDGE, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental ...
Once-weekly subcutaneous initiation dosing offers an at-home alternative for adults with MCI or mild dementia due to Alzheimer’s disease, potentially reducing infusion-center dependence and visit ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena administered via the CirCLIQ ® on-body injector (OBI) offers a ...
Sumitomo Pharma Co., Ltd announced that Novo Nordisk Pharma Ltd has received a partial change approval of the manufacturing and marketing authorization from the Ministry of Health, Labour and Welfare ...
TOKYO and CAMBRIDGE, Mass., May 8, 2026 /PRNewswire/ -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period ...
A new injection developed by researchers and an Australian biotechnology company may have a life-changing impact on an estimated nine out of 10 dogs that suffer from serious respiratory issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results